User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Search results

  1. Heart rate reduction as a goal in hypertension

    ... those of African origin have less activation of the renin-angiotensin-aldosterone system ( RAAS ) and lower levels of plasma renin ... angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists, and beta-blockers. However, age and ethnicity may not ...

  2. New drugs for hypertension: What's in the pipeline?

    ... arterial stiffness clinical trials Diuretics angiotensin II receptor blockers angiotensin converting enzyme inhibitors Calcium ...

  3. Recommended reading

    ... Journal of Renin-Angiotensin- Aldosterone System http://jra.sagepub.com/ Journal ... with a higher risk for mood disorder hospital admissions. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers may ... of accelerated stiffening of the aorta in the Whitehall II study participants. General adiposity by body mass index ( BMI ) and ...

  4. Hypertension in diabetic patients

    ... kidney and eye problems. The medication of choice is an angiotensin-converting enzyme inhibitor (ACEI) Background ... is hyper-reactive to both norepinephrine and angiotensin II, which increase peripheral vascular resistance. Insulin resistance ...

  5. Recommended reading – key published papers from 2017 as chosen by our Scientific Committee Members

    ... events 3)    No class of medications (i.e. angiotensin converting enzyme inhibitors, angiotensin-receptor blockers, ... and skeletal muscle oxidative capacity whereas angiotensin II elicits more subtle changes in fatty acid turnover.   Dzeshka MS, ...

  6. Scientific Highlights: 2015 Asia Pacific conference on cardiometabolic diseases management

    ... of stroke and major CV events’. Treatment with renin–angiotensin–aldosterone system (RAAS) blockers are effective in reducing ... infarction (MI) and in angina, in which RAAS blockade (with angiotensin-converting enzyme inhibitors [ACEIs] or angiotensin II receptor blockers [ARBs]) or calcium-channel blockers, respectively, are ...

  7. Complex management of comorbid hypertension, diabetes and thyroid disorders

    ... help prevent stroke and major CV events Renin–angiotensin–aldosterone system ( RAAS ) blockers may reduce the development ... enzyme inhibitors [ACEIs] or angiotensin II receptor blockers [ARBs]) or calcium-channel blockers, respectively, are ...

  8. Scientific Highlights: 2016 Asia Pacific conference on cardiometabolic diseases management

    ... more severe target organ damage and low response to renin-angiotensin system blockers, compared with patients from other ethnic ... angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, and mineralocorticoid receptor antagonists, in addition ...

  9. Congress Report: European Society of Cardiology (ESC) 2014

    ... in heart failure, it is relevant to hypertension because the angiotensin receptor-neprilysin inhibitor LCZ696 can be used in both conditions. In PARADIGM-HF 8442 patients with class II to IV heart failure and an ejection fraction of ≥40% were randomised to ...

  10. Scientific highlights: 4th European – Middle East forum on cardiovascular risks

    ... undergoing vascular surgery. Other medications such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) should only be considered with caution and ...

Pages